Tosatoxumab
- CAS No.
- 1374419-41-6
- Chemical Name:
- Tosatoxumab
- Synonyms
- Tosatoxumab;Research Grade Tosatoxumab;Research Grade Tosatoxumab (DXX00101)
- CBNumber:
- CB68080884
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MOL File:
- Mol file
- MSDS File:
- SDS
| Product description | Number | Pack Size | Price |
| Tosatoxumab 95.00% | CS-0627412 | 1mg | $325 |
| Tosatoxumab 95.00% | CS-0627412 | 5mg | $845 |
| Tosatoxumab 95.00% | CS-0627412 | 10mg | $1354 |
| Tosatoxumab Antibody 95.00% | orb1980471 | 1mg | $290 |
| Tosatoxumab Antibody 95.00% | orb1980471 | 5mg | $690 |
| form | Liquid |
|---|---|
| color | Colorless to light yellow |
| FDA UNII | 6AA3OC17QR |
Tosatoxumab price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0627412 | Tosatoxumab 95.00% | 1374419-41-6 | 1mg | $325 | 2026-06-04 | Buy |
| ChemScene | CS-0627412 | Tosatoxumab 95.00% | 1374419-41-6 | 5mg | $845 | 2026-06-04 | Buy |
| ChemScene | CS-0627412 | Tosatoxumab 95.00% | 1374419-41-6 | 10mg | $1354 | 2026-06-04 | Buy |
| Biorbyt Ltd | orb1980471 | Tosatoxumab Antibody 95.00% | 1374419-41-6 | 1mg | $290 | 2026-05-06 | Buy |
| Biorbyt Ltd | orb1980471 | Tosatoxumab Antibody 95.00% | 1374419-41-6 | 5mg | $690 | 2026-05-06 | Buy |
Tosatoxumab Chemical Properties,Uses,Production
Uses
Tosatoxumab (AR-301; KBSA301) is a human immunoglobulin G1 monoclonal antibody that specifically neutralizes alpha-toxin (alpha-hemolysin; Hla) of S. aureus. Tosatoxumab binds to an N-terminal epitope of alpha-toxin, thereby preventing functional toxin pore oligomerisation. Tosatoxumab has the potential for passive immunotherapy in the S. aureus pneumonia as an adjunctive therapy to standard antibiotic agent[1][2].
References
[1] Bruno Franois, et al. Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial. Intensive Care Med. 2018 Nov;44(11):1787-1796. DOI:10.1007/s00134-018-5229-2
[2] Philippe Vignon, et al. New Agents in Development for Sepsis: Any Reason for Hope Drugs. 2020 Nov;80(17):1751-1761. DOI:10.1007/s40265-020-01402-z
Tosatoxumab Preparation Products And Raw materials
Raw materials
Preparation Products
Tosatoxumab Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| ShangHai Biochempartner Co.,Ltd | 177-54423994 17754423994 | 2853530910@QQ.com | China | 8000 | 62 |
| Guangzhou Hongyuan Chemical Co.,Ltd | 15817493340 | 981810490@qq.com | China | 1577 | 58 |
| Wuhan Chemstan Biotechnology Co., Ltd. | 027-65317797 15926423062 | 422450190@qq.com | China | 10306 | 58 |
| Biolab Reagents | 027-65279366 18108604356 | products@biolabreagent.com | China | 9864 | 58 |
| Wuhan Jingkangen Biomedical Technology Co., Ltd | 13720134139 086-15871494362 13720134139 | orders@jknbiochem.com | China | 7282 | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11963 | 58 |
| Wuhan Acumen Bio-Technology Co.,ltd | 027-027-16602739303 16602739303 | 673003916@qq.com | China | 4588 | 58 |
| Changsha Fuzhen Biotechnology Co.，LTD | 15111215862 18229892877 | 3062105966@qq.com | China | 5550 | 58 |
| Olix ( Hubei) Pharmaceutical Technology Co., Ltd | 17316404525 17316404525 | 209533805@qq.com | China | 9769 | 58 |
| Atagenix Laboratories | 027-87008169 17762441161 | info@atagenix.com | China | 9997 | 58 |
